Literature DB >> 20827117

Peripheral nervous system manifestations of Sjögren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies.

Julius Birnbaum1.   

Abstract

Sjögren syndrome is among the most common autoimmune diseases affecting adults in the United States, and is frequently regarded as an immune-mediated exocrinopathy exclusively causing dry eyes and dry mouth. However, as a systemic rheumatic disease, there can be various "extraglandular" complications. The eclectic permutation of peripheral nervous system (PNS) syndromes which occur in Sjögren patients are among the most common and severe extraglandular complications. This review article highlights the evaluation, differential diagnosis, immunopathogenic mechanisms, and potential treatment options of these PNS complications encountered by neurologists. The sensory neuropathies constitute the most frequent PNS complication. Sjögren patients can suffer from severe neuropathic pain, with small-fiber neuropathy causing lancinating or burning pain which can disproportionately affect the proximal torso or extremities, and the face (ie, in a "non-length-dependent distribution"). The technique of skin biopsy, assessing for the intraepidermal nerve fiber density of unmyelinated nerves, provides a useful technique for neurologists to diagnose small-fiber neuropathies, especially when there is such a non-length-dependent distribution. Other diagnostic techniques (ie, electromyography/nerve-conduction studies, evoked potentials, nerve and muscle biopsy) may be useful in specific subtypes of neuropathies. A rational approach to treatment requires a careful appraisal of the clinical subtype of the neuropathy, as well as a familiarity with such discriminating immunopathogenic mechanisms. The application of the traditional armamentarium used for neuropathic pain can be especially challenging. Sjögren patients can suffer from debilitating fatigue, sicca symptoms, and autonomic findings; as such manifestations can be complications of various neuropathic agents, neurologists should understand how to minimize such iatrogenic complications. Therefore, this article will empower neurologists to more effectively collaborate with rheumatologists, in the diagnosis and treatment of Sjögren patients with PNS complications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20827117     DOI: 10.1097/NRL.0b013e3181ebe59f

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  27 in total

1.  Unusual presentation of Sjögren's syndrome.

Authors:  Aicha Bouraoui; Syed Farhan Bari; Julian Nash; Kenneth Dawson
Journal:  BMJ Case Rep       Date:  2014-11-20

2.  Sensory neuronopathy associated with tumor necrosis factor inhibitor therapy.

Authors:  Julius Birnbaum
Journal:  Neurol Clin Pract       Date:  2014-12

Review 3.  Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.

Authors:  Eleni I Kampylafka; Harry Alexopoulos; Marinos C Dalakas; Athanasios G Tzioufas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 4.  Diagnosis and therapeutic options for peripheral vasculitic neuropathy.

Authors:  Franz Blaes
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-04       Impact factor: 5.346

5.  Characterization of cognitive dysfunction in Sjögren's syndrome patients.

Authors:  Lynn C Epstein; Gina Masse; Jerold S Harmatz; Tammy M Scott; Athena S Papas; David J Greenblatt
Journal:  Clin Rheumatol       Date:  2013-12-15       Impact factor: 2.980

6.  [Sensory neuronopathy of Sjögren's syndrome. A diagnostic challenge].

Authors:  D Czell; R Baldinger; W Jochum; M Weber
Journal:  Nervenarzt       Date:  2012-02       Impact factor: 1.214

7.  Comparisons of presentations and outcomes of neuromyelitis optica patients with and without Sjögren's syndrome.

Authors:  Yu Hua Zhong; Zhi Gang Zhong; Zhou Zhou; Zhen Yu Ma; Meng Yao Qiu; Fu Hua Peng; Wei Xi Zhang
Journal:  Neurol Sci       Date:  2016-11-05       Impact factor: 3.307

Review 8.  Peripheral neuropathies in rheumatic disease--a guide to diagnosis.

Authors:  Jean-Michel Vallat; Magalie Rabin; Laurent Magy
Journal:  Nat Rev Rheumatol       Date:  2012-08-21       Impact factor: 20.543

9.  Non-length-dependent and length-dependent small-fiber neuropathies associated with tumor necrosis factor (TNF)-inhibitor therapy in patients with rheumatoid arthritis: expanding the spectrum of neurological disease associated with TNF-inhibitors.

Authors:  Julius Birnbaum; Clifton O Bingham
Journal:  Semin Arthritis Rheum       Date:  2013-10-30       Impact factor: 5.532

10.  Pain severity and neuropathic pain symptoms in primary Sjögren's syndrome: a comparison study of seropositive and seronegative Sjögren's syndrome patients.

Authors:  Barbara M Segal; Brian Pogatchnik; Lisa Henn; Kyle Rudser; Kathy Moser Sivils
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-08       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.